Asia Pacific Biotech Market Promises Immense Future Potential

The Asia Pacific biotech market is expected to grow at a CAGR of around 19% during 2010-2013 on the back of demographic factors and increasing investments in the industry, says RNCOS.

NOIDA, India (prHWY.com) June 6, 2011 - The Asia Pacific biotechnology market holds lot of growth potential, which is being tapped by the biotech companies through investments, thus driving the infrastructure and R&D in the sector. These areas of the industry are also being supported by various initiatives taken by the governments of the Asia Pacific countries. Flurry of investments can be attributed to the realization of the power held by the countries due to their population and disease prevalence. Through the biotech industry, the public and private sectors are aiming towards eradicating health problems and also driving economic prosperity. Backed by such undying support of the public and private sector, the Asia Pacific biotech sector will continue to grow at a fast pace in the future also.

According to our new research report, "Asia Pacific Biotechnology Market (2008-2012)", the Asia-Pacific biotech market is projected to grow at a CAGR of around 19% during 2010 - 2013. Growth of the biotech industry in the region will be headed by Japan, China, and South Korea, while higher growth rates will be witnessed in emerging markets, such as Malaysia, India, and Singapore.

The Asia Pacific biotech market will grow due to the upsurge in biosimilars, agri-biotech, and industrial biotech markets. While the biosimilars market will grow due to the flurry of patent expirations in near future, issues of food security will drive the agri-biotech sector. Hence, most of the biotech companies in the region are focusing on these sectors, and many other companies are planning their foray through planned investments and collaborations.

Our report, "Asia Pacific Biotechnology Market (2008-2012)", also discusses the emerging sectors, such as contract research and manufacturing, biobetters, bioinformatics, generics market etc. The report provides valuable information to pharmaceutical & biotechnology companies and investors, planning to enter these markets and will help them in devising strategies in accordance to the individual markets. The report also contains detail analysis and statistics of the market size, growth, share, segmentation, geographic distribution, trends in technology development, and profiling of key players of each country.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM138.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com/promotion.htm

About RNCOS:

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals study and analyze the industry and its various components, with comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the consultants in meeting their objectives in a cost-effective and timely manner.

###

Tag Words: biosimilars, vaccine

Categories: Health

Press Release Contact
B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

Link To This Press Release:

URL HTML Code